BlackRock Health Sciences Opportunities Portfolio Investor C Shares (SHSCX)
| Fund Assets | 6.01B |
| Expense Ratio | 1.86% |
| Min. Investment | $1,000 |
| Turnover | 43.00% |
| Dividend (ttm) | 6.69 |
| Dividend Yield | 14.26% |
| Dividend Growth | 19.86% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 9, 2025 |
| Previous Close | 46.94 |
| YTD Return | -6.20% |
| 1-Year Return | 8.73% |
| 5-Year Return | 11.91% |
| 52-Week Low | 44.15 |
| 52-Week High | 54.27 |
| Beta (5Y) | n/a |
| Holdings | 170 |
| Inception Date | Oct 16, 2000 |
About SHSCX
The BlackRock Health Sciences Opportunities Fund Investor C Shares is a mutual fund focused on equity investments within the health sciences sector. Its primary objective is to invest at least 80% of its assets in the common stock of companies involved in health sciences and related industries. This includes businesses operating in health care equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. The fund seeks to offer diversified exposure to both growth and value stocks across these healthcare-related segments, including opportunities in non-U.S. markets. With a track record dating back to 2000 and total assets exceeding $7.5 billion, the fund has established itself as a notable player in the sector, aiming to deliver returns with lower volatility compared to its peers. It holds around 145 individual securities and is managed by BlackRock’s specialized healthcare team, leveraging scientific expertise alongside financial analysis to identify compelling investment opportunities. The fund is recognized for its sector-specific focus and its role in providing investors broad access to the innovation-driven health sciences industry.
Performance
SHSCX had a total return of 8.73% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.69%.
Top 10 Holdings
46.92% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.34% |
| Johnson & Johnson | JNJ | 10.22% |
| AbbVie Inc. | ABBV | 4.11% |
| Gilead Sciences, Inc. | GILD | 3.96% |
| Merck & Co., Inc. | MRK | 3.55% |
| Amgen Inc. | AMGN | 3.49% |
| UnitedHealth Group Incorporated | UNH | 3.04% |
| Intuitive Surgical, Inc. | ISRG | 2.46% |
| Abbott Laboratories | ABT | 2.43% |
| Danaher Corporation | DHR | 2.31% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2025 | $2.85576 | Dec 10, 2025 |
| Jul 17, 2025 | $3.83665 | Jul 18, 2025 |
| Dec 11, 2024 | $3.09215 | Dec 12, 2024 |
| Jul 18, 2024 | $2.49135 | Jul 19, 2024 |
| Dec 7, 2023 | $0.99992 | Dec 8, 2023 |
| Jul 20, 2023 | $1.34151 | Jul 21, 2023 |